Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2025-12-25 @ 1:07 AM
NCT ID:
NCT03541993
Eligibility Criteria:
Inclusion Criteria:
* Individuals who provided informed consent.
* Those who didn't meet any of the exclusion criteria.
* Those who took hormonal contraception (e.g.: the pill, coil, implant, etc.) were eligible to participate in the current study.
Exclusion Criteria:
* Individuals below 18 years or above 35 years old at the time of giving consent.
* Individuals with Body Mass Index outside of the range 18-35 kg/m2.
* Individuals with blood pressure greater than 140/90 HH/mg.
* Those who smoke or have smoked.
* Individuals who have been living (for more than 3 months) at an altitude of 2000 m or over within the past 6 months.
* Individuals with a history of neurological, vascular or psychiatric illness (excluding depressive illness and anxiety).
* Individuals with a current diagnosis of depression and/or anxiety.
* Individuals with relevant learning difficulties, dyslexia, dyscalculia or colour blindness.
* Individuals with visual impairment that cannot be corrected with glasses or contact lenses.
* Individuals with frequent migraines that require medication (more than or equal to 1 per month).
* Individuals with disorders of the blood.
* Individuals with a heart disorder.
* Individuals with a respiratory disorder that requires regular medication (Note: asthma sufferers who only take their medication occasionally/as required are eligible for this study).
* Individuals with diabetes.
* Individuals with any food intolerances/sensitivities.
* Females participants who were pregnant, seeking to become pregnant, or currently lactating.
* Individuals currently taking any prescription medications.
* Individuals who have habitually used dietary supplements within the last month (defined as more than 3 consecutive days or 4 days in total).
* Individuals with a history of renal or hepatic disease, or other severe diseases of the gastrointestinal tract (e.g., iron accumulation, iron utilization disorders, hypercalcaemia, hypercalciuria), that are likely to interfere with metabolism/absorption/secretion of the product under investigation.
* Individuals with any health condition that would prevent fulfilment of the study requirements.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
35 Years
Study:
NCT03541993
Study Brief:
Protocol Section:
NCT03541993